IMPACT OF SARCOPENIA AND ADVANCED FIBROSIS ON CARDIOVASCULAR RISK IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE

被引：0
|
作者：
Lee, Jae Chang [1 ]
Kim, Kye Whon [1 ]
Kang, Min Kyu [1 ]
Lee, Yu Rim [2 ]
Jang, Se Young [2 ]
Kweon, Young Oh [2 ]
Tak, Won Young [3 ]
Park, Soo Young [2 ]
Park, Jung Gil [1 ]
机构：
[1] Yeungnam Univ, Coll Med, Internal Med, Gyongsan, South Korea
[2] Kyungpook Natl Univ, Sch Med, Internal Med, Daegu, South Korea
[3] Kyungpook Natl Univ, Sch Med, Daegu, Daegu, South Korea
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2574
引用
收藏
页码：S809 / S809
页数：1
相关论文
共 50 条
  • [31] Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes
    Shaikh, Sabhita Shabir
    Qazi-Arisar, Fakhar Ali
    Nafay, Saba
    Zaheer, Sidra
    Shaikh, Hafeezullah
    Azam, Zahid
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (01) : 54 - 64
  • [32] Sarcopenia is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease.
    Kang, Min Kyu
    Park, Jung Gil
    Kim, Min Cheol
    Lee, Heon Ju
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 421 - 421
  • [33] Sarcopenia Is Associated with Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
    Kang, Min Kyu
    Park, Jung Gil
    Kim, Min Cheol
    Park, Soo Young
    Lee, Heon Ju
    Tak, Won Young
    Kweon, Young-Oh
    Jang, Se Young
    Lee, Yu Rim
    HEPATOLOGY, 2018, 68 : 1306A - 1306A
  • [34] The Ability of Lipoprotein (a) Level to Predict Early Carotid Atherosclerosis Is Impaired in Patients With Advanced Liver Fibrosis Related to Metabolic-Associated Fatty Liver Disease
    Wu, Tingfeng
    Ye, Junzhao
    Shao, Congxiang
    Lin, Yansong
    Wang, Wei
    Feng, Shiting
    Zhong, Bihui
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2022, 13 (07) : e00504
  • [35] Assessing advanced fibrosis in metabolic-associated steatotic liver disease-The MAFLD fibrosis score
    Sharpton, Suzanne
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1234 - 1235
  • [36] Impact of the New Metabolic-Associated Fatty Liver Disease (MAFLD) on NAFLD Patients Classification in Italy
    Angelico, Francesco
    Pastori, Daniele
    Del Ben, Maria
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (12) : 2683 - 2684
  • [37] CLINICAL IMPACT OF METABOLIC-ASSOCIATED FATTY LIVER DISEASE ON LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA
    Shaikh, Anjiya
    Lymberopoulos, Peter
    Benhammou, Jihane N.
    Rich, Nicole E.
    Patel, Ankur
    Bhatnagar, Anshul
    Kim, Donghee
    Ahmed, Aijaz
    Rana, Abbas
    Lee, Tzu-Hao
    Cholankeril, George
    HEPATOLOGY, 2022, 76 : S879 - S879
  • [38] Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk
    Han, Eugene
    Lee, Yong-ho
    Kim, Young Dae
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Lee, Byung-Wan
    Kang, Eun Seok
    Cha, Bong-Soo
    Han, Kwang-Hyub
    Nam, Hyo Suk
    Heo, Ji Hoe
    Kim, Seung Up
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (04): : 584 - 595
  • [39] Development of a machine learning-based model to identify risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease
    Zhang, W.
    Yue, T.
    Ding, Y.
    Weng, J.
    Zheng, X.
    Luo, S.
    DIABETOLOGIA, 2024, 67 : S508 - S508
  • [40] The prothrombotic tendency of metabolic-associated fatty liver disease
    Swan, Dawn
    Lisman, Ton
    Tripodi, Armando
    Thachil, Jecko
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (11) : 3045 - 3055
12345